Pamela Esposito Replimune Group, Inc. (REPL) insider trading activity

Pamela Esposito is Chief Business Officer of Replimune Group, Inc.. Currently has a direct ownership of 263,436 shares of REPL, which is worth approximately $3.33 Million. The most recent transaction as insider was on Jul 15, 2021, when has been sold 4,600 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $4,646. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

0% 3M change

0% 12M change

Total Value Held $3.33 Million

Pamela Esposito Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2021	BUY Exercise of conversion of derivative security	$4,646 $1.01 p/Share	4,600 Added 2.1%	214,759 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	34,165 Added 13.98%	210,159 Common Stock
Jan 19 2021	SELL Open market or private sale	$245,173 $42.81 p/Share	5,727 Reduced 3.15%	175,994 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$5,784 $1.01 p/Share	5,727 Added 3.06%	181,721 Common Stock
Jan 15 2021	SELL Open market or private sale	$1,275,717 $43.58 p/Share	29,273 Reduced 14.26%	175,994 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$29,566 $1.01 p/Share	29,273 Added 12.48%	205,267 Common Stock
Jan 14 2021	SELL Open market or private sale	$900,400 $45.02 p/Share	20,000 Reduced 10.2%	175,994 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$20,200 $1.01 p/Share	20,000 Added 9.26%	195,994 Common Stock
Dec 23 2020	BUY Exercise of conversion of derivative security	$88,732 $1.75 p/Share	50,704 Added 22.37%	175,994 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$41,547 $3.3 p/Share	12,590 Added 9.13%	125,290 Common Stock
Oct 14 2020	SELL Open market or private sale	$521,600 $32.6 p/Share	16,000 Reduced 12.43%	112,700 Common Stock
Oct 14 2020	BUY Exercise of conversion of derivative security	$16,160 $1.01 p/Share	16,000 Added 11.06%	128,700 Common Stock

Also insider at

KYMR

Kymera Therapeutics, Inc. Healthcare

Pamela Esposito

Chief Business Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Value

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL

Account